ECP 2024

Discover the Future of Cancer Analysis with BIOTYPE at ECP 2024!

Join us at the European Congress of Pathology in Florence, Italy, September 7-11, and see how our innovative assays are revolutionizing genetic analysis in cancer diagnostics.

Our comprehensive assay portfolio supports the analysis of multiple cancer entities, including endometrial, colorectal, and bladder cancer and melanoma. Our solutions are designed to target key biomarkers such as MSI, POLE, and FGFR. Whether you’re looking to implement TCGA classification for endometrial cancer or profile mutations in solid tumors, our assays deliver precise, rapid results.

The modularity of the MODAPLEX platform allows you to combine the assays you need for different entities in a single, efficient run. This streamlined approach enables the detection of multiple modalities within 4 hours, conserving valuable FFPE tissue and facilitating quick, informed decisions.

Meet our experts at our booth #7 to learn more about how our innovative assays can optimize your diagnostic workflow.

We look forward to seeing you in Florence!